Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Mylan .
Filed returns
10
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2019 | Mylan | Health | Congratulations on election to the European Parliament & request to meet. (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2019 | Mylan | Health | SPC Manafacturing Waiver proposals in the European Parliament / Commission. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Mylan | Health | EU Pharmaceuticals in the Environment (PiE) Directive and related matters. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2019 | Mylan | Health | Healthcare policy best practice in Europe, and market developments in Ireland and Brussels. (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2019 | Mylan | Health | Healthcare policy developments in Ireland and Brussels (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2019 | Mylan | Health | improve health and business policy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2018 | Mylan | Health | Mylan, Medicines for Ireland and Medicines for Europe are committed to supporting industrial policy initiatives aimed at strengthening the European industrial base, increasing investments in R&D for generic, biosimilar… (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2018 | Mylan | Health | Engaging to share best policy practice in order to improve patient access to medicines in Ireland, and a stronger more sustainable and competitive industry (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2017 | Mylan | Health | Raise awareness of public health challenges of severe allergies and anaphylaxis. (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2017 | Mylan | Health | SPC Manufacturing Waiver currently under consideration at the European Parliament. We also gave an introduction to Mylan and outlined our policy positions on Ireland's weak biosimilars policy system and our policy… (Legislation) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 10 | 100.0% |